-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CIT-013 in Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CIT-013 in Colitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CIT-013 in Colitis Drug Details: Monoclonal antibodies are under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CIT-013 in Vasculitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CIT-013 in Vasculitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CIT-013 in Vasculitis Drug Details: Monoclonal antibodies are under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CIT-013 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CIT-013 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CIT-013 in Idiopathic Pulmonary Fibrosis Drug Details: Monoclonal antibodies are...
-
Government & Regulation
NewAustralia Mining Fiscal Landscape – Regulations Governance and Sustainability
Australia Mining Fiscal Landscape Report Overview Australia has abundant and diverse natural resources, including iron ore, coal, copper, and bauxite. Therefore, mining impacts the country’s national income, investments, jobs, exports, and government revenues significantly. Australia is the largest iron ore producer globally. The country’s federal and state governments have separate roles and responsibilities pertaining to resource exploration and development. Mineral resources are owned by the Australian government, or state or territory governments, rather than private individuals. The ‘Australia Mining Fiscal...
-
Government & Regulation
Canada Mining Fiscal Landscape – Regulations Governance and Sustainability
Canada Mining Fiscal Landscape Report Overview Canada is one of the largest mineral producers globally and produces more than 60 metals and minerals, including potash, uranium, platinum, indium, and aluminium, among others. Furthermore, Canada is one of the world's largest bauxite importers. Canada’s mining industry is governed by different departments and agencies under provincial governments. However, in cases such as mineral activities on federal lands and offshore areas, as well as the usage of uranium as a nuclear fuel, a...
-
Product Insights
Likelihood of Approval Analysis for Amino Acid Metabolism Disorders
Overview How likely is it that the drugs in Amino Acid Metabolism Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amino Acid Metabolism Disorders Overview Amino acids are building blocks...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DEN-181 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DEN-181 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DEN-181 in Rheumatoid Arthritis Drug Details: DEN-181 (Rheumavax) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Imidazolyl Ethanamide Pentandioic Acid in Chemotherapy Induced Neutropenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Imidazolyl Ethanamide Pentandioic Acid in Chemotherapy Induced Neutropenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Imidazolyl Ethanamide Pentandioic Acid in Chemotherapy Induced Neutropenia...
-
Company Insights
Innovation and Patenting activity of CIT Group Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CIT Group Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CIT-013 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CIT-013 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CIT-013 in Rheumatoid Arthritis Drug Details: Monoclonal antibodies are under development for the...